Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium-glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus - Kasichayanula, S; Chang, M; Hasegawa, M (Diabetes Obes Metab, 2011)
et al.